EP3487531A4 - Traitement de la démence fronto-temporale - Google Patents
Traitement de la démence fronto-temporale Download PDFInfo
- Publication number
- EP3487531A4 EP3487531A4 EP17831788.9A EP17831788A EP3487531A4 EP 3487531 A4 EP3487531 A4 EP 3487531A4 EP 17831788 A EP17831788 A EP 17831788A EP 3487531 A4 EP3487531 A4 EP 3487531A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- methods
- frontotemporal dementia
- treating frontotemporal
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662364013P | 2016-07-19 | 2016-07-19 | |
PCT/US2017/042846 WO2018017711A1 (fr) | 2016-07-19 | 2017-07-19 | Traitement de la démence fronto-temporale. |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3487531A1 EP3487531A1 (fr) | 2019-05-29 |
EP3487531A4 true EP3487531A4 (fr) | 2020-03-25 |
Family
ID=60992917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17831788.9A Withdrawn EP3487531A4 (fr) | 2016-07-19 | 2017-07-19 | Traitement de la démence fronto-temporale |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3487531A4 (fr) |
AU (1) | AU2017299579A1 (fr) |
CA (1) | CA3030872A1 (fr) |
IL (1) | IL264167A (fr) |
SG (1) | SG11201900123TA (fr) |
WO (1) | WO2018017711A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10201710758PA (en) | 2013-07-09 | 2018-02-27 | Annexon Inc | Anti-complement factor c1q antibodies and uses thereof |
BR112018010360A2 (pt) * | 2015-11-24 | 2018-12-04 | Annexon Inc | fragmentos fab de fator de complemento anti-c1q e utilizações dos mesmos |
CN108159421B (zh) * | 2018-02-05 | 2021-05-18 | 苏州大学 | 磷脂酰丝氨酸阻断剂在制备治疗血小板数量减少相关疾病药物中的用途 |
EP3873525A4 (fr) * | 2018-11-02 | 2022-07-13 | Annexon, Inc. | Compositions et procédés de traitement d'une lésion cérébrale |
TW202216760A (zh) | 2020-07-23 | 2022-05-01 | 愛爾蘭商歐薩爾普羅席納有限公司 | 抗類澱粉β (ABETA)抗體 |
US11958899B2 (en) | 2021-07-13 | 2024-04-16 | Mabwell Therapeutics Inc. | Anti-C1s antibodies and uses thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014066744A2 (fr) * | 2012-10-25 | 2014-05-01 | True North Therapeutics, Inc. | Anticorps de la c1s anti-complément et leurs utilisations |
WO2016073685A1 (fr) * | 2014-11-05 | 2016-05-12 | Annexon, Inc. | Anticorps humanisés anti-facteur du compément c1q et leurs utilisations |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8148330B2 (en) * | 2005-12-09 | 2012-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Modulation of synaptic maintenance |
US9480658B2 (en) * | 2005-12-09 | 2016-11-01 | The Board Of Trustees Of The Leland Stanford Junior University | Modulation of synaptic maintenance |
SG10201710758PA (en) * | 2013-07-09 | 2018-02-27 | Annexon Inc | Anti-complement factor c1q antibodies and uses thereof |
-
2017
- 2017-07-19 AU AU2017299579A patent/AU2017299579A1/en not_active Abandoned
- 2017-07-19 WO PCT/US2017/042846 patent/WO2018017711A1/fr unknown
- 2017-07-19 SG SG11201900123TA patent/SG11201900123TA/en unknown
- 2017-07-19 EP EP17831788.9A patent/EP3487531A4/fr not_active Withdrawn
- 2017-07-19 CA CA3030872A patent/CA3030872A1/fr not_active Abandoned
-
2019
- 2019-01-09 IL IL264167A patent/IL264167A/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014066744A2 (fr) * | 2012-10-25 | 2014-05-01 | True North Therapeutics, Inc. | Anticorps de la c1s anti-complément et leurs utilisations |
WO2016073685A1 (fr) * | 2014-11-05 | 2016-05-12 | Annexon, Inc. | Anticorps humanisés anti-facteur du compément c1q et leurs utilisations |
Non-Patent Citations (4)
Title |
---|
LUI HANSEN ET AL: "Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation", CELL, ELSEVIER, AMSTERDAM, NL, vol. 165, no. 4, 21 April 2016 (2016-04-21), pages 921 - 935, XP029530775, ISSN: 0092-8674, DOI: 10.1016/J.CELL.2016.04.001 * |
S. K. SINGHRAO ET AL: "Role of complement in the aetiology of Pick's disease?", JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1 May 1996 (1996-05-01), pages 578 - 593, XP055665408, Retrieved from the Internet <URL:https://academic.oup.com/jnen/article-pdf/55/5/578/8276203/55-5-578.pdf> [retrieved on 20200205] * |
See also references of WO2018017711A1 * |
TSAI RICHARD M ET AL: "Treatment of Frontotemporal Dementia", CURRENT TREATMENT OPTIONS IN NEUROLOGY, SPRINGER US, BOSTON, vol. 16, no. 11, 21 September 2014 (2014-09-21), pages 1 - 14, XP035395075, ISSN: 1092-8480, [retrieved on 20140921], DOI: 10.1007/S11940-014-0319-0 * |
Also Published As
Publication number | Publication date |
---|---|
IL264167A (en) | 2019-02-28 |
AU2017299579A1 (en) | 2019-01-24 |
WO2018017711A1 (fr) | 2018-01-25 |
EP3487531A1 (fr) | 2019-05-29 |
SG11201900123TA (en) | 2019-02-27 |
CA3030872A1 (fr) | 2018-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3423109A4 (fr) | Thérapie pour démence frontotemporale | |
EP3206494A4 (fr) | Compositions et méthodes pour traiter des troubles du snc | |
EP3206493A4 (fr) | Compositions et méthodes pour traiter des troubles du snc | |
EP3224269A4 (fr) | Compositions et procédés pour traiter des troubles du snc | |
EP3405577B8 (fr) | Compositions et procédés pour inhiber le facteur d | |
EP3250210A4 (fr) | Compositions et méthodes pour le traitement des troubles du snc | |
EP3302379A4 (fr) | Compositions et méthodes pour le traitement du ptérygion | |
EP3277270A4 (fr) | Compositions et procédés permettant de traiter une anémie | |
EP3408344A4 (fr) | Procédés et compositions de traitement de puits | |
EP3209298A4 (fr) | Compositions et méthodes pour traiter l'insomnie | |
EP3458158A4 (fr) | Compositions et procédés permettant de traiter l'eczéma | |
EP3487531A4 (fr) | Traitement de la démence fronto-temporale | |
EP3220906A4 (fr) | Compositions et procédés de traitement de troubles lysosomaux | |
EP3442543A4 (fr) | Compositions et méthodes pour la neurogenèse | |
EP3189036A4 (fr) | Compositions et méthodes pour traiter des troubles prolifératifs | |
EP3280420A4 (fr) | Compositions et méthodes permettant de traiter des troubles du snc | |
EP3458079A4 (fr) | Compositions et méthodes pour le traitement de l'acné | |
EP3405191A4 (fr) | Méthodes et compositions pour le traitement de l'hyperhidrose | |
EP3368048A4 (fr) | Méthodes et compositions pour le traitement de l'amyloïdose | |
EP3313387A4 (fr) | Méthodes et compositions pour le traitement de troubles neurodégénératifs | |
EP3262065A4 (fr) | Procédés et compositions de traitement des dystroglycanopathies | |
EP3445369A4 (fr) | Compositions et méthodes pour traiter la démence | |
EP3432913A4 (fr) | Méthodes et compositions pour le traitement de l'athérosclérose | |
EP3169684A4 (fr) | Méthodes et compositions pour le traitement de troubles liés au vih | |
EP3411367A4 (fr) | Compositions et méthodes de traitement d'infections bactériennes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20190219 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20200220 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 39/395 20060101AFI20200215BHEP Ipc: G01N 33/53 20060101ALI20200215BHEP Ipc: A61P 25/00 20060101ALI20200215BHEP Ipc: A61K 49/16 20060101ALI20200215BHEP Ipc: G01N 33/532 20060101ALI20200215BHEP Ipc: C07K 16/18 20060101ALI20200215BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20201125 |